Par/NNP Pharmaceutical/NNP Inc./NNP said/VBD 0/-NONE- it/PRP named/VBD its/PRP$ interim/JJ president/NN and/CC chief/JJ executive/JJ officer/NN ,/, Kenneth/NNP I./NNP Sawyer/NNP ,/, to/TO those/DT posts/NNS permanently/RB ,/, and/CC elected/VBD him/PRP to/TO the/DT board/NN ./.
Par/NNP also/RB said/VBD 0/-NONE- it/PRP was/VBD advised/VBN *-1/-NONE- by/IN the/DT U.S./NNP attorney/NN for/IN Maryland/NN that/IN it/PRP is/VBZ one/CD of/IN a/DT number/NN of/IN companies/NNS being/VBG investigated/VBN */-NONE- by/IN a/DT federal/JJ grand/JJ jury/NN for/IN alleged/JJ violations/NNS of/IN the/DT federal/JJ Food/NNP ,/, Drug/NNP and/CC Cosmetic/NNP Act/NNP ./.
Par/NNP ,/, a/DT generic-drug/NN maker/NN that/WDT *T*-2/-NONE- has/VBZ been/VBN plagued/VBN *-1/-NONE- by/IN management/NN problems/NNS ,/, was/VBD already/RB the/DT subject/NN of/IN a/DT federal/JJ criminal/JJ inquiry/NN into/IN the/DT drug-approval/JJ process/NN and/CC a/DT Food/NNP and/CC Drug/NNP Administration/NNP investigation/NN ./.
A/DT Par/NNP spokesman/NN said/VBD 0/-NONE- he/PRP understood/VBD 0/-NONE- the/DT criminal/JJ investigation/NN in/IN Maryland/NNP relates/VBZ to/TO matters/NNS 0/-NONE- Par/NNP disclosed/VBD *T*-1/-NONE- in/IN July/NNP ,/, when/WRB Par/NNP said/VBD 0/-NONE- it/PRP filed/VBD false/JJ drug/NN information/NN with/IN the/DT FDA/NNP *T*-2/-NONE- ./.
At/IN the/DT time/NN ,/, the/DT company/NN said/VBD 0/-NONE- it/PRP was/VBD recalling/VBG one/CD of/IN its/PRP$ drugs/NNS and/CC had/VBD stopped/VBN *-1/-NONE- selling/VBG two/CD others/NNS ./.
The/DT spokesman/NN said/VBD 0/-NONE- he/PRP also/RB understood/VBD that/IN the/DT inquiry/NN related/VBD to/TO the/DT existence/NN of/IN an/DT ``/`` off-the-record/JJ ''/'' production/NN book/NN ./.
The/DT book/NN noted/VBD changes/NNS made/VBN */-NONE- at/IN the/DT manufacturing/NN level/NN that/WDT *T*-1/-NONE- were/VBD n't/RB disclosed/VBN *-2/-NONE- to/TO the/DT FDA/NNP ./.
Par/NNP said/VBD 0/-NONE- it/PRP is/VBZ cooperating/VBG in/IN the/DT investigation/NN ./.
Also/RB yesterday/NN ,/, Ashok/NNP Patel/NNP ,/, a/DT former/JJ Par/NNP official/NN who/WP *T*-2/-NONE- pleaded/VBD guilty/JJ to/TO *-3/-NONE- providing/VBG an/DT FDA/NNP employee/NN an/DT illegal/JJ gratuity/NN of/IN $/$ 3,000/CD *U*/-NONE- ,/, was/VBD sentenced/VBN *-1/-NONE- by/IN a/DT federal/JJ judge/NN in/IN Baltimore/NNP to/TO one/CD year/NN of/IN community/NN service/NN and/CC a/DT $/$ 150,000/CD *U*/-NONE- fine/NN ./.
Mr./NNP Patel/NNP also/RB was/VBD placed/VBN *-1/-NONE- on/IN three/CD years/NNS '/POS probation/NN ./.
Mr./NNP Patel/NNP resigned/VBD as/IN senior/JJ vice/NN president/NN of/IN Par/NNP in/IN April/NNP ./.
In/IN July/NNP ,/, Par/NNP and/CC a/DT 60%-owned/JJ unit/NN agreed/VBD *-1/-NONE- to/TO plead/VB guilty/JJ in/IN that/DT inquiry/NN ,/, as/IN did/VBD another/DT former/JJ Par/NNP official/NN *?*/-NONE- ./.
Mr./NNP Sawyer/NNP began/VBD *-1/-NONE- running/VBG the/DT company/NN on/IN an/DT interim/JJ basis/NN in/IN late/JJ September/NNP ./.
Par/NNP said/VBD 0/-NONE- it/PRP selected/VBD him/PRP for/IN the/DT posts/NNS of/IN president/NN and/CC chief/JJ executive/NN on/IN a/DT permanent/JJ basis/NN because/IN of/IN his/PRP$ experience/NN in/IN the/DT industry/NN and/CC his/PRP$ performance/NN at/IN Par/NNP ./.
Perry/NNP Levine/NNP ,/, chairman/NN ,/, said/VBD 0/-NONE- Mr./NNP Sawyer/NNP had/VBD ``/`` taken/VBN significant/JJ steps/NNS ''/'' 0/-NONE- *T*-1/-NONE- to/TO restore/VB the/DT company/NN 's/POS credibility/NN and/CC sense/NN of/IN professionalism/NN and/CC integrity/NN ./.

